Prevalence, determinants and outcomes of traditional, complementary and alternative medicine use for hypertension among low-income households in Malaysia and the Philippines.
Blood pressure
Hypertension
Non-communicable disease control, Malaysia
Philippines
Traditional, complementary and alternative medicine
Journal
BMC complementary medicine and therapies
ISSN: 2662-7671
Titre abrégé: BMC Complement Med Ther
Pays: England
ID NLM: 101761232
Informations de publication
Date de publication:
30 Sep 2022
30 Sep 2022
Historique:
received:
09
12
2021
accepted:
19
09
2022
entrez:
30
9
2022
pubmed:
1
10
2022
medline:
5
10
2022
Statut:
epublish
Résumé
Traditional, complementary and alternative medicine (TCAM) is used to treat a broad range of conditions. In low- and middle-income countries (LMICs), TCAM use is particularly common among those with low socio-economic status. To better understand the patterns and impact of TCAM use on the management of non-communicable diseases in these populations, this study examines the prevalence and characteristics of TCAM use for hypertension, its determinants, and its association with hypertension management outcomes and wellbeing among low-income adults in two Southeast Asian countries at different levels of economic and health system development, Malaysia and the Philippines. We analysed cross-sectional data from 946 randomly selected adults diagnosed with hypertension from low-income rural and urban communities in Malaysia (n = 495) and the Philippines (n = 451). We compared the prevalence, characteristics and household expenditure on TCAM use between countries and used multi-level, mixed-effects regression to estimate associations between TCAM use and its determinants, and five hypertension management outcomes and wellbeing. The prevalence of TCAM use to manage hypertension was higher in the Philippines than in Malaysia (18.8% vs 8.8%, p < 0.001). Biologically-based modalities, e.g. herbal remedies, were the most common type of TCAM used in both countries, mainly as a complement, rather than an alternative to conventional treatment. Households allocated around 10% of health spending to TCAM in both countries. Belief that TCAM is effective for hypertension was a positive predictor of TCAM use, while belief in conventional medicine was a negative predictor. TCAM use was not strongly associated with current use of medications for hypertension, self-reported medication adherence, blood pressure level and control, or wellbeing in either country. A small, but significant, proportion of individuals living in low-income communities in Malaysia and the Philippines use TCAM to manage their hypertension, despite a general lack of evidence on efficacy and safety of commonly used TCAM modalities. Recognising that their patients may be using TCAM to manage hypertension will enable health care providers to deliver safer, more patient-centred care.
Sections du résumé
BACKGROUND
BACKGROUND
Traditional, complementary and alternative medicine (TCAM) is used to treat a broad range of conditions. In low- and middle-income countries (LMICs), TCAM use is particularly common among those with low socio-economic status. To better understand the patterns and impact of TCAM use on the management of non-communicable diseases in these populations, this study examines the prevalence and characteristics of TCAM use for hypertension, its determinants, and its association with hypertension management outcomes and wellbeing among low-income adults in two Southeast Asian countries at different levels of economic and health system development, Malaysia and the Philippines.
METHODS
METHODS
We analysed cross-sectional data from 946 randomly selected adults diagnosed with hypertension from low-income rural and urban communities in Malaysia (n = 495) and the Philippines (n = 451). We compared the prevalence, characteristics and household expenditure on TCAM use between countries and used multi-level, mixed-effects regression to estimate associations between TCAM use and its determinants, and five hypertension management outcomes and wellbeing.
RESULTS
RESULTS
The prevalence of TCAM use to manage hypertension was higher in the Philippines than in Malaysia (18.8% vs 8.8%, p < 0.001). Biologically-based modalities, e.g. herbal remedies, were the most common type of TCAM used in both countries, mainly as a complement, rather than an alternative to conventional treatment. Households allocated around 10% of health spending to TCAM in both countries. Belief that TCAM is effective for hypertension was a positive predictor of TCAM use, while belief in conventional medicine was a negative predictor. TCAM use was not strongly associated with current use of medications for hypertension, self-reported medication adherence, blood pressure level and control, or wellbeing in either country.
CONCLUSIONS
CONCLUSIONS
A small, but significant, proportion of individuals living in low-income communities in Malaysia and the Philippines use TCAM to manage their hypertension, despite a general lack of evidence on efficacy and safety of commonly used TCAM modalities. Recognising that their patients may be using TCAM to manage hypertension will enable health care providers to deliver safer, more patient-centred care.
Identifiants
pubmed: 36180884
doi: 10.1186/s12906-022-03730-x
pii: 10.1186/s12906-022-03730-x
pmc: PMC9526286
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
252Subventions
Organisme : Medical Research Council
ID : MC_PC_16026
Pays : United Kingdom
Organisme : Wellcome Trust/Newton Fund-MRC Humanities & Social Science Collaborative Award
ID : 200346/Z/15/Z
Informations de copyright
© 2022. The Author(s).
Références
Int J Clin Pract. 2012 Oct;66(10):924-39
pubmed: 22994327
Soc Sci Med. 2006 Feb;62(4):858-65
pubmed: 16099574
BMC Complement Med Ther. 2022 Apr 12;22(1):104
pubmed: 35413882
Curr Hypertens Rep. 2017 Sep 18;19(9):77
pubmed: 28921053
BMJ Glob Health. 2018 Oct 31;3(5):e000895
pubmed: 30483405
BMC Complement Altern Med. 2016 Mar 08;16:92
pubmed: 26952043
Int J Epidemiol. 2006 Jun;35(3):751-5
pubmed: 16481364
Patient Prefer Adherence. 2019 Oct 25;13:1829-1837
pubmed: 31749609
J Tradit Complement Med. 2015 Mar 18;6(4):321-326
pubmed: 27774413
J Altern Complement Med. 2009 Apr;15(4):331-9
pubmed: 19388855
BMC Health Serv Res. 2015 Jul 03;15:254
pubmed: 26135302
BMJ Glob Health. 2020 Feb 11;5(2):e002040
pubmed: 32133191
Lancet. 2011 Feb 19;377(9766):680-9
pubmed: 21269677
J Rural Health. 2012 Jan;28(1):101-12
pubmed: 22236320
J Acupunct Meridian Stud. 2019 Apr;12(2):43-51
pubmed: 30059774
BMC Complement Altern Med. 2016 Jun 11;16:176
pubmed: 27289517
BMC Complement Altern Med. 2016 Nov 8;16(1):446
pubmed: 27825376
Soc Sci Med. 2022 May;300:114570
pubmed: 34802782
Scand J Public Health. 2018 Jun;46(4):448-455
pubmed: 28975853
Altern Ther Health Med. 2011 Mar-Apr;17(2):50-9
pubmed: 21717826
J Multidiscip Healthc. 2019 Jul 22;12:573-582
pubmed: 31413584
BMC Complement Altern Med. 2019 Sep 18;19(1):258
pubmed: 31533697
Med J Malaysia. 2005 Oct;60(4):454-9
pubmed: 16570707
Evid Based Complement Alternat Med. 2012;2012:697237
pubmed: 23346210
Hypertension. 2013 Jun;61(6):1360-83
pubmed: 23608661
BMC Complement Altern Med. 2018 Apr 2;18(1):114
pubmed: 29609580
Evid Based Complement Alternat Med. 2016;2016:6987636
pubmed: 27843480
Health Policy Plan. 2020 Oct 1;35(8):1070-1083
pubmed: 32516397
BMJ Open. 2018 Jul 30;8(7):e024000
pubmed: 30061449
JAMA. 2013 Sep 4;310(9):959-68
pubmed: 24002282
Complement Ther Med. 2009 Oct-Dec;17(5-6):292-9
pubmed: 19942109
J Clin Hypertens (Greenwich). 2014 Nov;16(11):773-81
pubmed: 25157607
BMJ. 2012 Jul 09;345:e3953
pubmed: 22777025
Int J Equity Health. 2013 Mar 11;12:18
pubmed: 23496984
Chin J Integr Med. 2018 Aug;24(8):584-590
pubmed: 28028721
J Altern Complement Med. 2012 Dec;18(12):1108-20
pubmed: 22924383
J Hum Hypertens. 2015 Mar;29(3):143-51
pubmed: 24990417
PLoS One. 2019 Jul 10;14(7):e0219266
pubmed: 31291293
PLoS One. 2014 Nov 06;9(11):e112124
pubmed: 25375256
BMJ Glob Health. 2020 Jul;5(7):
pubmed: 32646854
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326